Doxycycline Injection, Powder, Lyophilized, For Solution
Product Images NDC 68382-911

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxycycline (NDC 68382-911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (530f87fb C1d3 496f A350 A9621c1ae1cc 01)

The text describes a chemical compound with a molecular formula of C22H24N20sg *HCI)2 * C2HsO * H20 and a molecular weight of 1025.89. The name of the compound is not provided.*

FDA Label Image

100 mg (530f87fb C1d3 496f A350 A9621c1ae1cc 02)

This is a product description for Doxycycline for Injection, USP. It is packaged in a single-dose vial containing 100 mg of doxycycline. The vial stoppers do not contain natural rubber latex. It is manufactured by Cadia Healthcare in Ahmedabad, India and distributed by Zydus Pharmaceuticals in Pennington, NJ. The drug must be stored between 20° and 25°C and protected from light. It is for intravenous infusion only and the solution needs to be diluted before use. The vial contains additional ingredients including ascorbic acid and mannitol. The usual dosage is included in the insert.*

FDA Label Image

Vial Label (530f87fb C1d3 496f A350 A9621c1ae1cc 03)

This is a medication called Doxycycline for injection, USP that needs to be stored between 20°C and 25°C. It is a single-dose vial containing 100mg per vial to be used for intravenous infusion only. The reconstituted solution should be diluted and protected from light. Each vial contains Doxycycline hyclate equivalent to 100mg doxycycline, ascorbic acid 480mg, and manitol 300mg. It is manufactured by Cadia Healthcare Ltd in Vadodara, India, and distributed by Zydus Pharmaceuticals (USA) Inc. It is important to protect the solution from sunlight during the infusion. This product comes with a lot number and is available in a preservative-free form.*

FDA Label Image

100 mg (530f87fb C1d3 496f A350 A9621c1ae1cc 04)

This appears to be a list of different product names, numbers, and quantities. The product mentioned is "Doxycycline for Injection, USP" which comes in vials containing 100 mg and is sold in packs of 10 single-dose vials. There may be additional information missing such as usage instructions or warnings.*

FDA Label Image

Carton Label (530f87fb C1d3 496f A350 A9621c1ae1cc 05)

This text is not informative and contains only two words and a drug name which is not enough to generate a useful description.*

FDA Label Image

200 mg (530f87fb C1d3 496f A350 A9621c1ae1cc 06)

This text is a product label description for Doxycycline for injection, USP indicating its manufacturer, specifications, and warnings. The medication is a sterile, preservative-free, and lyophilized solution with 200mg doxycycline hyclate equivalent. It requires dilution before intravenous infusion, and the usual dosage should be obtained from the insert. It is essential to protect the solution from direct sunlight during infusion and protect it from light while retaining it in the carton until its time of use to prevent degradation. The label also indicates its storage temperature and the presence of a non-natural rubber latex vial stopper.*

FDA Label Image

200 mg (530f87fb C1d3 496f A350 A9621c1ae1cc 07)

The text seems to be a description of Doxycycline, an antibiotic, for intravenous infusion. It is a single-dose vial of 200 mg per vial, which must be diluted and reconstituted before use. The vial contains Doxycycline hyclate equivalent to 200 mg doxycycline, ascorbic acid 960 mg, and mannitol 600 mg. The usual adult dosage is 200 mg on the first day followed by a maintenance dose of 100 to 200 mg per day depending on the severity of infection. The reconstituted solutions must be used or discarded within the time period and must be protected from direct sunlight during infusion. This medication is distributed by Zydus Pharmaceuticals (USA) Inc. and manufactured by Cadila Healthcare Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.